Dermatology

Login Register

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Parthika Patel

M. Pharm (Pharmaceutics)

Parthika Patel has completed her Graduated B.Pharm from SSR COLLEGE OF PHARMACY and done M.Pharm in Pharmaceutics. She can be contacted at [email protected]. Contact no. 011-43720751

Home

Parthika Patel

Articles By : Parthika Patel

Former GlaVellaian Karuppiah Joins Shilpa Medicare as COO

Shilpa Medicare Names Pharma Veteran Vellaian Karuppiah as COO, Formulations

Written By Parthika Patel25 April 2026 5:25 PM IST

New Delhi: Shilpa Medicare Limited has appointed Dr Vellaian Karuppiah as Chief Operating Officer (COO), Formulations with effect from April 23, 2026,...

No Distinction Between House Mark and Trademark: Bombay HC Grants Relief to Sun Pharma, Bars ABSUN

Sun Pharma Submits Binding USD 13 Billion Bid for Organon, Deal May Be India's Largest Pharma Acquisition: Report

Written By Parthika Patel24 April 2026 1:00 PM IST

New Delhi: Sun Pharmaceutical Industries has emerged as the frontrunner in the race to acquire US-based Organon & Co. after submitting a binding...

Alembic Secures USFDA Approval for Gilenya Generic

Alembic Enters Philippines Market with New Subsidiary for Pharma Distribution

Written By Parthika Patel24 April 2026 12:45 PM IST

New Delhi: Alembic Pharmaceuticals Limited has incorporated a new subsidiary, Alembic Lifesciences Philippines Inc., with a share capital of PHP 12...

Cipla Gets USFDA Approval for Albuterol Inhaler, Expands US Respiratory Portfolio

Written By Parthika Patel23 April 2026 1:00 PM IST

Mumbai: Cipla Limited has received final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application...

Morepen Labs Clears USFDA Inspection With Zero Observations at Himachal API Facility

Written By Parthika Patel23 April 2026 12:15 PM IST

New Delhi: Morepen Laboratories Limited has successfully completed a United States Food and Drug Administration (USFDA) inspection at its API...

Ajanta Pharma Gets 5 USFDA Observations for Paithan Facility

Written By Parthika Patel22 April 2026 12:30 PM IST

New Delhi: Ajanta Pharma Limited has informed that the US Food and Drug Administration (USFDA) has completed its inspection of its manufacturing...

Contract Pharmacists Protest at SMS Medical College, Demand Reinstatement, Recruitment Probe

Written By Parthika Patel22 April 2026 11:00 AM IST

Jaipur: Tensions have escalated at the super speciality wing of SMS Medical College as contract pharmacists have issued a seven-day ultimatum to the...

Fire Erupts at Erythro Pharma Facility in Sangareddy, Probe Launched

Written By Parthika Patel21 April 2026 11:45 PM IST

New Delhi: A massive fire broke out at Erythro Pharma Limited in the Gaddapotharam Industrial Area of Sangareddy district following a suspected...

Eris Lifesciences Receives HALMED Observations on Ahmedabad Units, Plans Corrective Actions

Written By Parthika Patel21 April 2026 11:45 PM IST

New Delhi: Eris Lifesciences Limited has informed that HALMED, Croatia's Agency for Medicinal Products and Medical Devices, conducted an inspection of...

CDSCO Reorganises Workforce, Transfers 95 Officials Amid Rising Compliance Concerns

Written By Parthika Patel21 April 2026 11:45 PM IST

New Delhi: In a major administrative move aimed at strengthening regulatory oversight and improving efficiency, the Central Drugs Standard Control...

Gurugram Bust: Rs 70 Lakh Counterfeit Eli Lilly Mounjaro Recovered, 2 Arrested

Written By Parthika Patel20 April 2026 7:30 PM IST

New Delhi: In a major enforcement action, two individuals were arrested in Gurugram after the drugs control department seized a consignment of...

Lupin Launches Bioequivalent of Xigduo XR in US Across Multiple Strengths

Lupin Limited Gets 3 Observations After USFDA Inspection of Somerset Facility

Written By Parthika Patel20 April 2026 7:00 PM IST

New Delhi: Lupin Limited has informed that the United States Food and Drug Administration (USFDA) has concluded an inspection at its manufacturing...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok